Rocatinlimab
Amgen
['atopic dermatitis ', 'derm', 'imab ']
late-breaking research at #eadvcongress shared by rocatinlimab demonstrates improvements in head and neck atopic dermatitis in patients with moderate-severe disease in a phase 2 trial #milan #eadv202 #research #dermatology #innovation 
Official Twitter account for the Department of Dermatology @mountsinainyc. Leaders in dermatological treatment, care, research and education.